30% off. Use code SUMMERSALE30 at checkout for 30% off for 12 months on Plus, Pro and Premium subscriptions. Subscribe now
United States Pharmaceuticals

Liquidia Technologies Inc (LQDA)

Track

The most recent insider trading activity occurred in November 2020, with significant sell transactions by Eshelman Ventures, LLC totaling over $1.4 million. Prior to this, Eshelman Ventures, LLC engaged in several buy transactions earlier in 2020. Other transactions include smaller sell-offs by Timothy Albury in August 2019 and a planned sale by Benjamin Maynor in February 2019.
Stock chart
Ticker: LQDA Exchange: NAS
Preparing chart...
Download chart Copy chart image Copy link Share to X Share


Subscribe to get access to the transaction volume chart and in-chart transaction details
• Purchase • Sale • Planned purchase • Planned sale Net purchase Net sale Activity signal Earnings
Top insiders
Trades
Eshelman Ventures, LLC
1 sale — total 54,349 USD
Sale 25 Nov 2020
Value US$557,754.19 | Price 236.27 | Shares 19,486
Sale 24 Nov 2020
Value US$1,512,072.35 | Price 20.76 | Shares 84,196
Sale 23 Nov 2020
Value US$421,346.69 | Price 3.16 | Shares 133,346
Buy 2 Jul 2020
Value US$15,000,000.00 | Price 8.00 | Shares 1,875,000
Buy 6 Apr 2020
Value US$233,715.22 | Price 5.28 | Shares 44,250
Buy 3 Apr 2020
Value US$169,739.50 | Price 4.85 | Shares 35,000
Buy 2 Apr 2020
Value US$35,792.13 | Price 4.96 | Shares 7,223
Buy 1 Apr 2020
Value US$220,122.00 | Price 4.89 | Shares 45,000
Buy 31 Mar 2020
Value US$146,112.00 | Price 4.87 | Shares 30,000
Buy 30 Mar 2020
Value US$67,106.13 | Price 4.76 | Shares 14,100
Buy 27 Dec 2019
Value US$999,997.44 | Price 3.13 | Shares 319,488
Sale 22 Aug 2019
Value US$40,572.00 | Price 6.00 | Shares 6,762
Sale 14 Aug 2019
Value US$3,029.00 | Price 6.50 | Shares 466
Sale 13 Aug 2019
Value US$6,495.20 | Price 7.06 | Shares 920
Planned sale 28 Feb 2019
Value US$42,440.82 | Price 19.86 | Shares 2,137
Planned sale 28 Feb 2019
Value US$947.50 | Price 18.95 | Shares 50
Planned sale 22 Feb 2019
Value US$7,923.42 | Price 18.09 | Shares 438
Planned sale 22 Feb 2019
Value US$3,567.96 | Price 16.83 | Shares 212
Planned sale 22 Feb 2019
Value US$4,638.19 | Price 15.83 | Shares 293
Planned sale 22 Jan 2019
Value US$123,988.20 | Price 14.84 | Shares 8,355
Planned sale 22 Jan 2019
Value US$41,953.38 | Price 14.14 | Shares 2,967
Buy 14 Nov 2018
Value US$16,557.50 | Price 18.50 | Shares 895
Buy 13 Nov 2018
Value US$1,890.00 | Price 18.00 | Shares 105
Buy 8 Nov 2018
Value US$18,250.00 | Price 18.25 | Shares 1,000
Buy 30 Jul 2018
Value US$8,000,003.00 | Price 11.00 | Shares 727,273
Buy 30 Jul 2018
Value US$6,000,005.00 | Price 11.00 | Shares 545,455
Buy 30 Jul 2018
Value US$6,000,005.00 | Price 11.00 | Shares 545,455
Buy 30 Jul 2018
Value US$8,000,003.00 | Price 11.00 | Shares 727,273
Buy 30 Jul 2018
Value US$6,000,005.00 | Price 11.00 | Shares 545,455
Buy 30 Jul 2018
Value US$6,000,005.00 | Price 11.00 | Shares 545,455
Buy 30 Jul 2018
Value US$1,636,998.00 | Price 11.00 | Shares 148,818
Buy 30 Jul 2018
Value US$6,000,005.00 | Price 11.00 | Shares 545,455
Buy 30 Jul 2018
Value US$6,000,005.00 | Price 11.00 | Shares 545,455
Buy 30 Jul 2018
Value US$1,500,004.00 | Price 11.00 | Shares 136,364
Abbreviations B: Buy, S: Sell, PP: Planned purchase, PlS: Planned sale, PrS: Proposed sale, O: Option / Other
Notification date Transaction date B/S Transaction type Insider and/or position Nb. shares
Price
Value 		Number of shares Price Value Details
2020-11-27 2020-11-25 S Sale
2.9
Eshelman Ventures, LLC
Large shareholder
19,486 +40.2%
236.27
US$557,754 		19,486 +40.2% 236.27 US$557,754
2020-11-25 2020-11-24 S Sale
2.9
Eshelman Ventures, LLC
Large shareholder
84,196 +14.1%
20.76
US$1,512,072 		84,196 +14.1% 20.76 US$1,512,072
2020-11-24 2020-11-23 S Sale
2.9
Eshelman Ventures, LLC
Large shareholder
64,783 +43.0%
461.09
US$3,257,369 		64,783 +43.0% 461.09 US$3,257,369
2020-07-02 2020-07-02 B Purchase
2.9
Eshelman Ventures, LLC
Large shareholder
1,875,000 +36.3%
8.00
US$15,000,000 		1,875,000 +36.3% 8.00 US$15,000,000
2020-04-07 2020-04-06 B Purchase
2.9
Eshelman Ventures, LLC
Large shareholder
44,250 +33.7%
5.28
US$233,715 		44,250 +33.7% 5.28 US$233,715
2020-04-07 2020-04-03 B Purchase
2.9
Eshelman Ventures, LLC
Large shareholder
35,000 +36.3%
4.85
US$169,740 		35,000 +36.3% 4.85 US$169,740
2020-04-03 2020-04-02 B Purchase
2.9
Eshelman Ventures, LLC
Large shareholder
7,223 +8.1%
4.96
US$35,792 		7,223 +8.1% 4.96 US$35,792
2020-04-03 2020-04-01 B Purchase
2.9
Eshelman Ventures, LLC
Large shareholder
45,000 +102.0%
4.89
US$220,122 		45,000 +102.0% 4.89 US$220,122
2020-04-01 2020-03-31 B Purchase
2.9
Eshelman Ventures, LLC
Large shareholder
30,000 +212.8%
4.87
US$146,112 		30,000 +212.8% 4.87 US$146,112
2020-04-01 2020-03-30 B Purchase
2.9
Eshelman Ventures, LLC
Large shareholder
14,100 +inf%
4.76
US$67,106 		14,100 +inf% 4.76 US$67,106
2020-01-10 2019-12-27 B Purchase
3.9
Canaan VIII LP
Large shareholder
319,488 +12.3%
3.13
US$999,997 		319,488 +12.3% 3.13 US$999,997
2019-08-26 2019-08-22 S Sale Albury Timothy

SVP, Chief Accounting Officer

Officer
6,762 -14.8%
6.00
US$40,572 		6,762 -14.8% 6.00 US$40,572
2019-08-15 2019-08-14 S Sale Albury Timothy

SVP, Chief Accounting Officer

Officer
466 -1.2%
6.50
US$3,029 		466 -1.2% 6.50 US$3,029
2019-08-15 2019-08-13 S Sale Albury Timothy

SVP, Chief Accounting Officer

Officer
920 -2.4%
7.06
US$6,495 		920 -2.4% 7.06 US$6,495
2019-03-01 2019-02-28 PlS Planned sale
Maynor Benjamin

SVP, Research and Development

Officer
2,137 -33.9%
19.86
US$42,441 		2,137 -33.9% 19.86 US$42,441
2019-03-01 2019-02-28 PlS Planned sale
Maynor Benjamin

SVP, Research and Development

Officer
50 -0.8%
18.95
US$948 		50 -0.8% 18.95 US$948
2019-02-22 2019-02-22 PlS Planned sale
2.4
GORDON KEVIN K

President and CFO

Officer
438 -0.3%
18.09
US$7,923 		438 -0.3% 18.09 US$7,923
2019-02-22 2019-02-22 PlS Planned sale
2.4
GORDON KEVIN K

President and CFO

Officer
212 -0.1%
16.83
US$3,568 		212 -0.1% 16.83 US$3,568
2019-02-22 2019-02-22 PlS Planned sale
2.4
GORDON KEVIN K

President and CFO

Officer
293 -0.2%
15.83
US$4,638 		293 -0.2% 15.83 US$4,638
2019-01-24 2019-01-22 PlS Planned sale
2.4
GORDON KEVIN K

President and CFO

Officer
8,355 -4.9%
14.84
US$123,988 		8,355 -4.9% 14.84 US$123,988
2019-01-24 2019-01-22 PlS Planned sale
2.4
GORDON KEVIN K

President and CFO

Officer
2,967 -1.7%
14.14
US$41,953 		2,967 -1.7% 14.14 US$41,953
2018-11-15 2018-11-14 B Purchase Kirsch Arthur S Non-Executive Director
895 +81.0%
18.50
US$16,558 		895 +81.0% 18.50 US$16,558
2018-11-15 2018-11-13 B Purchase Kirsch Arthur S Non-Executive Director
105 +10.5%
18.00
US$1,890 		105 +10.5% 18.00 US$1,890
2018-11-13 2018-11-08 B Purchase Kirsch Arthur S Non-Executive Director
1,000 +inf%
18.25
US$18,250 		1,000 +inf% 18.25 US$18,250
2018-08-01 2018-07-30 B Purchase Canaan VIII LP Large shareholder
727,273 +39.6%
11.00
US$8,000,003 		727,273 +39.6% 11.00 US$8,000,003
2018-08-01 2018-07-30 B Purchase SANDELL SCOTT D Large shareholder
545,455 +28.1%
11.00
US$6,000,005 		545,455 +28.1% 11.00 US$6,000,005
2018-08-01 2018-07-30 B Purchase BASKETT FOREST Large shareholder
545,455 +28.1%
11.00
US$6,000,005 		545,455 +28.1% 11.00 US$6,000,005
2018-08-01 2018-07-30 B Purchase Bloch Stephen M Non-Executive Director
727,273 +39.6%
11.00
US$8,000,003 		727,273 +39.6% 11.00 US$8,000,003
2018-08-01 2018-07-30 B Purchase BARRIS PETER J Large shareholder
545,455 +28.1%
11.00
US$6,000,005 		545,455 +28.1% 11.00 US$6,000,005
2018-08-01 2018-07-30 B Purchase New Enterprise Associates 12, Limited Partnership Large shareholder
545,455 +28.1%
11.00
US$6,000,005 		545,455 +28.1% 11.00 US$6,000,005
2018-08-01 2018-07-30 B Purchase GLAXOSMITHKLINE PLC
148,818 +31.3%
11.00
US$1,636,998 		148,818 +31.3% 11.00 US$1,636,998
2018-08-01 2018-07-30 B Purchase KERINS PATRICK J Large shareholder
545,455 +28.1%
11.00
US$6,000,005 		545,455 +28.1% 11.00 US$6,000,005
2018-08-01 2018-07-30 B Purchase BARRETT M JAMES Large shareholder
545,455 +28.1%
11.00
US$6,000,005 		545,455 +28.1% 11.00 US$6,000,005
2018-08-01 2018-07-30 B Purchase Alexandria Venture Investments, LLC Large shareholder
136,364 +52.5%
11.00
US$1,500,004 		136,364 +52.5% 11.00 US$1,500,004
Explore more

More insider trading research around Liquidia Technologies Inc

More insider trades in United States
Similar Healthcare companies with insider activity
More Pharmaceuticals & Medical Research companies with insider activity
More Pharmaceuticals companies with insider activity
Insider trading in North America